Yellow fever in Brazil
from history to the risk of reemergency
DOI:
https://doi.org/10.11606/issn.1679-9836.v98i5p334-340Keywords:
Yellow fever, Virology, Epidemiology, History, Vaccination, BrazilAbstract
Yellow Fever is an infectious disease caused by the Yellow Fever virus (YFV), belonging to the genus Flavivirus. The disease is transmitted by arthropod bites and occurs exclusively in Central and South America and Africa periodically causing isolated outbreaks or epidemics of significant public health impact. The treatment of this disease is aimed at combating clinical symptoms, and there is no specific medicine against the virus. The present study made a survey of epidemiological and vaccine data in Brazil through a search in the main databases. It was observed that in 2017, with the most severe epidemic outbreak in the last 30 years, with approximately 800 reported cases, the Ministry of Health had as its strategy the intensification of vaccination in areas with imminent risk of virus circulation, distributing more than 17 million doses of the vaccine. However, the reemergence of Yellow Fever is a potential risk in cities with high population density of the urban vector, becoming a major public health problem.
Downloads
References
Vasconcelos PF. Febre amarela. Rev Soc Bras Med Trop. 2003;36(2):275-93. http://dx.doi.org/10.1590/S0037-86822003000200012.
Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1(1):11-20. doi: 10.1016/S1473-3099(01)00016-0.
Vasconcelos PFR, Pinheiro FP, Rosa JFST. Arboviroses. In: Veronesi R. Tratado de infectologia. 3a ed. São Paulo: Atheneu; 2005. v.1, p. 289-302.
Fonseca BAL, Figueiredo LTM. Dengue. In: Veronesi R. Tratado de infectologia. 3a ed. São Paulo: Atheneu; 2005. v. 1, p. 343-56.
Figueiredo LT. Febres hemorrágicas por vírus no Brasil. Rev Soc Bras Med Trop. 2006;39(2):203-10. http://dx.doi.rg/10.1590/S0037-86822006000200014.
Figueiredo LTdF, B.A.L. Febre amarela. In: Veronesi: Tratado de Infectologia. 3a ed. São Paulo: Atheneu; 2005. p.389-97.
Franco O. História da febre amarela no Brasil. Rev Bras Malariol Doenças Trop. 1969;21:315-520.
Fonseca BAL, Figueiredo LTM. Dengue. In: Veronesi: Tratado de infectologia. 3a ed. São Paulo: Atheneu; 2005. p.343-56.
dos Santos CN, Post PR, Carvalho R, Ferreira, II, Rice CM, Galler R. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. Virus Res. 1995;35(1):35-41. doi: 10.1016/0168-1702(94)00076-o.
Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985;229(4715):726-33. doi: 10.1126/science.4023707
Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649-88. doi: 10.1146/annurev.mi.44.100190.003245.
Knipe DMH, Peter M. Flaviviridae. In: Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p.1101-303.
Stiasny K, Heinz FX. Flavivirus membrane fusion. J Gen Virol. 2006;87(Pt 10):2755-66. doi: 10.1099/vir.0.82210-0.
Figueiredo LT. The recent arbovirus disease epidemic in Brazil. Rev Soc Bras Med Trop. 2015;48(3):233-4. doi: 10.1590/0037-8682-0179-2015.
Benchimol JL. História da febre amarela no Brasil. Hist Ciên Saúde-Manguinhos. 1994;1(1):121-4. http://dx.doi.org/10.1590/S0104-59701994000100010.
Gould EA, Solomon T. Pathogenic flaviviruses. Lancet. 2008;371(9611):500-9. https://doi.org/10.1016/S0140-6736(08)60238-X.
De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis. 2004;8(6):390-8. doi: /S1413-86702004000600002
Philip Samuel P, Tyagi BK. Diagnostic methods for detection & isolation of dengue viruses from vector mosquitoes. Indian J Med Res. 2006;123(5):615-28.
de Morais Bronzoni RV, Baleotti FG, Ribeiro Nogueira RM, Nunes M, Moraes Figueiredo LT. Duplex reverse transcription-PCR followed by nested PCR assays for detection and identification of Brazilian alphaviruses and flaviviruses. J Clin Microbiol. 2005;43(2):696-702. doi: 10.1128/JCM.43.2.696-702.2005
Elnifro EM, Ashshi AM, Cooper RJ, Klapper PE. Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev. 2000;13(4):559-70. doi: 10.1128/cmr.13.4.559-570.2000
Kuno G. Universal diagnostic RT-PCR protocol for arboviruses. J Virol Methods. 1998;72(1):27-41.
Hughes HR, Russell BJ, Mossel EC, Kayiwa J, Lutwama J, Lambert AJ. Development of a real-time RT-PCR assay for the global differentiation of yellow fever virus vaccine adverse events from natural infections. J Clin Microbiol. 2018;56(6):pii: e00323-18. doi: 10.1128/JCM.00323-18.
Wilson HL, Tran T, Druce J, Dupont-Rouzeyrol M, Catton M. Neutralization Assay for Zika and Dengue Viruses by Use of Real-Time-PCR-Based Endpoint Assessment. J Clin Microbiol. 2017;55(10):3104-12. doi: 10.1128/JCM.00673-17
Muller VD, Russo RR, Cintra AC, Sartim MA, Alves-Paiva Rde M, Figueiredo LT, et al. Crotoxin and phospholipases A(2) from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses. Toxicon. 2012;59(4):507-15. 2004;8(6):390-8. doi: 10.1016/j.toxicon.2011.05.021.
Vidotto A, Morais AT, Ribeiro MR, Pacca CC, Terzian AC, Gil LH, et al. Systems biology reveals NS4B-cyclophilin A Interaction: a new target to inhibit YFV replication. J Proteome Res. 2017;16(4):1542-55. doi: 10.1021/acs.jproteome.6b00933.
Pacca CC, Marques RE, Espindola JWP, Filho G, Leite ACL, Teixeira MM, et al. Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus. Biomed Pharmacother. 2017;87:381-7. doi: 10.1016/j.biopha.2016.12.112.
Albarnaz JD, De Oliveira LC, Torres AA, Palhares RM, Casteluber MC, Rodrigues CM, et al. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target. Antiviral Res. 2014;111:82-92. doi: 10.1016/j.antiviral.2014.09.004.
Pacca CC, Severino AA, Mondini A, Rahal P, D’Avila S G, Cordeiro JA, et al. RNA interference inhibits yellow fever virus replication in vitro and in vivo. Virus Genes. 2009;38(2):224-31. doi: 10.1007/s11262-009-0328-3.
Benchimol JL. Febre amarela: a doença e a vacina, uma história inacabada. Rio de Janeiro: Editora FIOCRUZ; 2001.
Brasil. Ministério da Saúde. Vacinação Febre amarela. Brasília; 2017. Disponível em: http://www.saude.gov.br/assessoria-de-imprensa/920-saude-de-a-a-z/febre-amarela/10771-vacinacao-febre-amarela.
World Health Organization (WHO). Yellow fever 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/yellow-fever.
Fonseca BF. Febre amarela. In: Veronesi R. Tratado de infectologia. São Paulo: Atheneu; 1996. p.251-7.
Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017-2026. Wkly Epidemiol Rec. 2017;92(16):193-204. doi: https://apps.who.int/iris/handle/10665/255703.
Hamlet A, Jean K, Yactayo S, Benzler J, Cibrelus L, Ferguson N, et al. POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa. Vaccine. 2019;37(11):1384-8. doi: https://doi.org/10.1016/j.vaccine.2019.01.074
Hughes HR, Kayiwa J, Mossel EC, Lutwama J, Staples JE, Lambert AJ. Phylogeny of yellow fever virus, Uganda, 2016. Emerg Infect Dis. 2018;24(8). doi: 10.3201/eid2408.180588.
Douam F, Ploss A. Yellow fever virus: knowledge gaps impeding the fight against an old foe. Trends Microbiol. 2018;26(11):913-28. doi: 10.1016/j.tim.2018.05.012.
Pan American Health Organization. World Health Organization. Epidemiological Update Yellow Fever. 6 March 2019. Washington, DC: PAHO/WHO; 2019. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=yellow-fever-2194&alias=47954-6-march-2019-yellow-fever-epidemiological-update&Itemid=270&lang=en.
Tauil PL, Santos JB, Moraes MAP. Febre amarela. Dinâmicas das doenças infecciosas e parasitárias. II. Rio de Janeiro: Guanabara Koogan; 2005. p.1755-65.
Brasil. Ministério da Saúde. Febre amarela: sintomas, tratamento, diagnóstico e prevenção Brasília; 2019. Disponível em: http://www.saude.gov.br/saude-de-a-z/febre-amarela-sintomas-transmissao-e-prevencao.
Van der Stuyft P, Gianella A, Pirard M, Cespedes J, Lora J, Peredo C, et al. Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet. 1999;353(9164):1558-62. doi: 10.1016/s0140-6736(99)03291-2.
Brasil. Ministério da Saúde. Monitoramento de febre amarela no Brasil. Brasília; 2008. Disponível em: http://www.saude.campinas.sp.gov.br/doencas/febre_amarela/boletim_febre_amarela_09_12_09.pdf.
Pivetta M. A ameaça da febre amarela. Rev Pesqui Fapesp. 2017;253. Disponível em: https://revistapesquisa.fapesp.br/2017/03/17/a-ameaca-da-febre-amarela/.
Brasil. Ministério da Saúde. Monitoramento de febre amarela no Brasil. Brasília; 2019. Disponível em: https://portalarquivos2.saude.gov.br/images/pdf/2019/junho/13/Informe-de-Monitoramento-de-Febre-Amarela-Brasil--n-18.pdf.
São Paulo (Estado). Governo. Secretaria de Estado da Saúde. Coordenadoria de Controle de Doenças. Centro de Vigilância Epidemiológica Prof. Alexandre Vranjac. Divisão de Zoonoses. Boletim epidemiológico febre amarela - 2018. São Paulo; 2018. Disponível em: http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/doencas-de-transmissao-por-vetores-e-zoonoses/doc/famarela/fa18_boletim_epid_0312.pdf.
São Paulo (Estado). Governo. Secretaria de Estado da Saúde. Coordenadoria de Controle de Doenças. Centro de Vigilância Epidemiológica Prof. Alexandre Vranjac. Divisão de Zoonoses. Boletim epidemiológico febre amarela, 2017: São Paulo; 2017. Disponível em: http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/doencas-de-transmissao-por-vetores-e-zoonoses/doc/famarela/fa17_2612boletim_epidemiologico.pdf.
Massad E, Burattini MN, Coutinho FA, Lopez LF. Dengue and the risk of urban yellow fever reintroduction in Sao Paulo State, Brazil. Rev Saude Publica. 2003;37(4):477-84. doi: http://dx.doi.org/10.1590/S0034-89102003000400013.
Figueiredo LT. The Brazilian flaviviruses. Microbes Infect. 2000;2(13):1643-9. doi: https://doi.org/10.1016/S1286-4579(00)01320-4.
